Stay updated on CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial
Sign up to get notified when there's something new on the CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial page.

Latest updates to the CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial page
- Check5 days agoChange DetectedUpdate to Revision: v3.0.2; the old Revision: v3.0.1 was removed and the 'Back to Top' element was deleted, with no other substantive changes.SummaryDifference0.3%
- Check12 days agoChange DetectedThe page has been updated to version 3.0.1, and the topic of multiple myeloma has been removed from the MedlinePlus Genetics section.SummaryDifference0.6%
- Check19 days agoChange DetectedThe web page has updated its facility name and location details, specifically emphasizing 'Plasma cell myeloma' and 'Hemic and Lymphatic Diseases' while removing previous references to 'Multiple Myeloma' and certain location terms.SummaryDifference2%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check40 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check48 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference2%
Stay in the know with updates to CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial page.